載入...
Improved anti-tumor activity and safety of interleukin-13 receptor targeted cytotoxin by systemic continuous administration in head and neck cancer xenograft model.
BACKGROUND: IL-13 receptor (IL-13R) targeted cytotoxin, IL13-PE38QQR, has been shown to have very potent anti-tumor activity to IL-13R-expressing head and neck tumor cells in vitro and in vivo. However, its effect is limited in aggressive tumors. To further improve the anti-tumor activity and safety...
Na minha lista:
Main Authors: | , , , |
---|---|
格式: | Artigo |
語言: | Inglês |
出版: |
2002
|
主題: | |
在線閱讀: | https://ncbi.nlm.nih.gov/pmc/articles/PMC2040009/ https://ncbi.nlm.nih.gov/pubmed/12435859 |
標簽: |
添加標簽
沒有標簽, 成為第一個標記此記錄!
|